Correction to “Nanoemulsion Based Lipid Nanoparticles for Effective Demethylcantharidin Delivery to Cure Liver Cancer”

IF 3.2 4区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Chemical Biology & Drug Design Pub Date : 2024-07-30 DOI:10.1111/cbdd.14603

引用次数: 0

Abstract

Z. Yan, T. Yu, X. Wu, et al., “Nanoemulsion Based Lipid Nanoparticles for Effective Demethylcantharidin Delivery to Cure Liver Cancer,” Chemical Biology & Drug Design 104, no. 1 (2024), e14580, https://doi.org/10.1111/cbdd.14580.

In Paragraph 6 of the “3.1 | Preparation and characterization of DNLNs” section, the text “the zeta potential of DNLNs was −8.21 ± 2.12 mV” was incorrect. This should have read “the zeta potential of DNLNs was −4.87 ± 0.31 mV.”

We apologize for this error.

查看原文本刊更多论文

更正 "基于纳米乳液的脂质纳米颗粒可有效递送去甲斑蝥素以治疗肝癌"。

Z.Yan, T. Yu, X. Wu, et al., "Nanoemulsion Based Lipid Nanoparticles for Effective Demethylcantharidin Delivery to Cure Liver Cancer," Chemical Biology & Drug Design 104, no.我们对此表示歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemical Biology & Drug Design 医学-生化与分子生物学

CiteScore

5.10

自引率

3.30%

发文量

164

审稿时长

4.4 months

期刊介绍： Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.